Contact our responsive and friendly client services team any time.
(03) 9028 2888
clients@freshequities.com
Investor presentation - Bionomics Limited
Health
Bionomics Limited (BNO) is an Australian biopharmaceutical company focused on the discovery and development of cancer, central nervous system disorders such as anxiety, depression and Alzheimer's Disease. BNO partners with pharmaceutical companies to get the drugs through the later stages of development and into the market.
Read moreMarket Cap
Price at Close
4w avg. Volume
4w avg. Turnover
announcement | t+2 movement | date |
---|---|---|
| -3.03% | 19 Jan 2021 |
| +3.45% | 17 Jan 2021 |
| 0.00% | 07 Jan 2021 |
| 0.00% | 03 Jan 2021 |
| +10.71% | 18 Dec 2020 |
| +8.00% | 24 Nov 2020 |
| -3.85% | 20 Nov 2020 |
| -3.85% | 20 Nov 2020 |
| -3.85% | 19 Nov 2020 |
| +8.33% | 18 Nov 2020 |
Current Price
52WK HIGH
52WK LOW
1YR RETURN
1YR RETURN VS. SECTOR
90 DAY RETURN
ASX RANK
/2,048
SECTOR RANK
/168
SHARES OUTSTANDING
Health
Bionomics Limited (BNO) is an Australian biopharmaceutical company focused on the discovery and development of cancer, central nervous system disorders such as anxiety, depression and Alzheimer's Disease. BNO partners with pharmaceutical companies to get the drugs through the later stages of development and into the market.
Read moreMarket Cap
Price at Close
4w avg. Volume
4w avg. Turnover
ASX:BNO is not raising right now
Want to invest?
(03) 9028 2888
clients@freshequities.com
Level 7, 388 Bourke St
Melbourne VIC 3000
Australia